Generating a T cell tumor-specific immune response in vivo: can flt3-ligand-generated dendritic cells tip the balance? H. J. McKenna REVIEW Pages: 281 - 286
The induction of distinct cytokine cascades correlates with different effects of granulocyte-colony stimulating factor and granulocyte/macrophage-colony-stimulating factor on the lymphocyte compartment in the course of high-dose chemotherapy for breast cancer Maurizio SettiDonatella BignardiFrancesco Indiveri ORIGINAL PAPER Pages: 287 - 296
Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model Kazuki YamanakaIsao HaraSadao Kamidono ORIGINAL ARTICLE Pages: 297 - 302
An EGP-2/Ep-CAM-expressing transgenic rat model to evaluate antibody-mediated immunotherapy Pamela M. J. McLaughlinBart-Jan KroesenLou F. M. H. de Leij ORIGINAL ARTICLE Pages: 303 - 311
ImmTher, a lipophilic disaccharide derivative of muramyl dipeptide, up-regulates specific monocyte cytokine genes and activates monocyte-mediated tumoricidal activity Laura L. WorthShu-Fang JiaEugenie S. Kleinerman ORIGINAL ARTICLE Pages: 312 - 320
Gene therapy with cytokine-transfected xenogenic cells (Vero-IL-2) in patients with metastatic solid tumors: mechanism(s) of elimination of the transgene-carrying cells Peter JantscheffRichard HerrmannChristoph Rochlitz ORIGINAL ARTICLE Pages: 321 - 330
The role of possible risk factors for acute and late renal dysfunction after high-dose interleukin-2, interferon α and lymphokine-activated killer cells Wim H. J. KruitPaul I. M. SchmitzGerrit Stoter ORIGINAL ARTICLE Pages: 331 - 335
Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4+ T cells Steven C. EckLaurence A. Turka SHORT COMMUNICATION Pages: 336 - 341